How to use SilverCancer Copilot.
Open silvercancer.com/copilot. No setup required. Tell the Copilot which country you practice in — it will adapt its answers accordingly. History is stored locally in your browser.
Each response includes: GRADE certainty rating with reasoning, evidence synthesis citing key trials by name, the relevant guideline recommendation for your country, local regulatory and reimbursement context, and recruiting trials when found.
Always verify critical information: For high-stakes decisions, check the primary source. The Copilot shows its reasoning — interrogate it. Reimbursement status changes — confirm current status with your institution.
Include your country, tumour type, biomarker and line of therapy. The Copilot searches ClinicalTrials.gov, EU CTR and EudraCT simultaneously and returns country-filtered results. Always confirm eligibility with the trial site before referring a patient.
No. Frame queries clinically without identifying details. See our Privacy Policy.
PubMed/Cochrane: 48-hour lag. Trial registry status: daily. ESMO guidelines: within 72 hours. EMA/ANVISA/Health Canada decisions: within 24–48 hours.
Email hello@silvercancer.com. We are actively expanding and prioritise markets based on demand.
Email clinical@silvercancer.com with the query and the response.